MedTrace Logo

Healthcare Disparities in Alopecia Areata

NCT05727306 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4052231

Last updated 2025-06-18

Study results available
· View outcomes & findings →

Summary

Alopecia areata (AA) is a common immune-mediated non-scarring alopecia often associated with substantial morbidity. There are however, limited population-based data on potential disparities in the burden of AA, including across people of different ethnicities and deprivation.

We aimed to provide the first large-scale, population-based estimate of lifetime risk of AA overall and by important sociodemographic subgroups. As AA is associated with an increased burden of mental health conditions and work-related outcomes (unemployment, time off work), a detailed understanding of the burden of disease in different sociodemographic groups is vital to plan resource provision.

Conditions

Interventions

OTHER

No intervention

Observational analysis of usual care only.

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • University of Oxford

    collaborator OTHER

  • Momentum Data

    lead INDUSTRY

Principal Investigators

  • Andrew McGovern, MD · Momentum Data

Eligibility

Min Age
12 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2024-07-24
Completion
2024-08-06

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05727306 on ClinicalTrials.gov